2007
Managing multiple and extensively drug-resistant tuberculosis and HIV
Padayatchi N, Friedland G. Managing multiple and extensively drug-resistant tuberculosis and HIV. Expert Opinion On Pharmacotherapy 2007, 8: 1035-1037. PMID: 17516869, DOI: 10.1517/14656566.8.8.1035.Peer-Reviewed Original Research
2005
Generic antiretroviral efficacy in AIDS-associated Kaposi's sarcoma in sub-Saharan Africa
Mosam A, Cassol E, Page T, Bodasing U, Cassol S, Dawood H, Friedland GH, Scadden DT, Aboobaker J, Jordaan JP, Lalloo UG, Esterhuizen TM, Coovadia HM. Generic antiretroviral efficacy in AIDS-associated Kaposi's sarcoma in sub-Saharan Africa. AIDS 2005, 19: 441-443. PMID: 15750399, DOI: 10.1097/01.aids.0000161775.36652.85.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyKaposi's sarcomaCopies/Generic antiretroviral therapyUndetectable viral loadActive antiretroviral therapyGeneric antiretroviral drugsAntiretroviral efficacyViral loadAntiretroviral drugsLog10 declineClinical experienceSarcomaTherapySaharan AfricaSub-Saharan AfricaHIVPatientsAIDSBaseline
2004
Implementing antiretroviral therapy in resource-constrained settings
Karim S, Karim Q, Friedland G, Lalloo U, Sadr W. Implementing antiretroviral therapy in resource-constrained settings. AIDS 2004, 18: 975-979. PMID: 15096799, DOI: 10.1097/00002030-200404300-00004.Peer-Reviewed Original Research
2003
Antiretroviral treatment and research in resource-poor countries
Pawinski R, Bobat R, Friedland G, Jeena P, Lalloo U. Antiretroviral treatment and research in resource-poor countries. The Lancet 2003, 361: 435. PMID: 12573414, DOI: 10.1016/s0140-6736(03)12415-4.Peer-Reviewed Original Research
2002
Report on the XIV International AIDS Conference.
Abdool Karim SS, Currier J, del Rio C, Feinberg J, Friedland GH, Sax PE, Zuger A. Report on the XIV International AIDS Conference. Infectious Diseases 2002, 14: 77-85. PMID: 12236208.Peer-Reviewed Original Research